BioTelemetry (BEAT) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 1% as investors watch Middle East supply disruptionsÂ
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
BioTelemetry, Inc. Reports Third Quarter 2014 Financial Results
October 30, 2014 4:05 PM EDTMALVERN, Pa., Oct. 30, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2014.
Company Highlights
Revenue increased 35% to $43.1 million, which includes 9% organic growth Experienced ninth consecutive quarter of year over year revenue growth Serviced over 135,000 patients in the quarter, doubling the prior year volume Generated positive adjusted EBITDA of $6.0 million Announced the reinstatement of... More